Clinical Trials Sponsored by Ludek Stehlik

Total 30 results

Ludek Stehlik
University Hospital Olomouc; University Hospital, Motol; Ministry of Health,...

Suspended

Biodegradable Stents in the Management of Stenoses of the Large Airways

Tracheal Stenosis

Czechia
Josef Stehlik

Completed

Link-HF: Multisensor Non-invasive Telemonitoring System for Prediction of Heart Failure Exacerbation (LINK-HF)

Cardiac Failure

United States
Telik

Completed

Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma

Multiple Myeloma | B Cell Lymphoma | Mantle Cell Lymphoma

United States
Telik

Completed

TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer

Ovarian Neoplasms

United States
Telik

Completed

Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome (MDS)

United States
Telik

Completed

TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer

Ovarian Neoplasms

United States
Telik

Completed

Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer

Carcinoma, Non-small-cell Lung

United States
Telik

Completed

Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Non Small Cell Lung Carcinoma

United States, Australia, Brazil, Chile, Germany, Argentina, Italy, United Kingdom
Telik

Terminated

Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer (ASSIST-5)

Ovarian Neoplasms

United States, United Kingdom, Belgium, Brazil
Telik

Terminated

Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
Telik

Terminated

Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)

United States
Telik

Completed

Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome

United States
Telik

Completed

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Telik

Completed

TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer

Ovarian Neoplasms

United States, Czech Republic, South Africa, Argentina, Belgium, Spain, Brazil, Chile, Germany, Hungary, Ireland, Netherlands, United Kingdom
Telik

Completed

Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer

Ovarian Neoplasms

United States
Telik

Terminated

Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)

United States
Telik

Terminated

Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia

Severe Chronic Neutropenia

United States
Telik

Completed

Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome (MDS)

United States
Telik

Completed

Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-small-cell Lung

United States
Telik

Completed

TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer

Ovarian Neoplasms

United States
Telik

Completed

Phase 2 Study of TLK286 in Metastatic Breast Cancer

Breast Neoplasms

United States
Telik

Completed

TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

United States
Telik

Completed

Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome

Myelodysplastic Syndromes

United States
Josef Stehlik
Merck Sharp & Dohme LLC

Recruiting

The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation

Heart Failure | Heart Failure With Reduced Ejection Fraction (HFrEF)

United States
Svehlik Martin, MD PhD
University of Graz

Completed

A Prospective Study of Two Home Based Muscle Strengthening Programs for Children With Cerebral Palsy

Cerebral Palsy

Austria
New Mexico Cancer Care Alliance
Christus Stehlin Foundation for Cancer Research

Completed

Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma

Advanced Solid Tumors | Lymphomas

United States
Arkadiusz Z. Dudek, MD
Merck Sharp & Dohme LLC; Big Ten Cancer Research Consortium

Completed

Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma:

Clear Cell Renal Carcinoma

United States
Arkadiusz Z. Dudek, MD
Bristol-Myers Squibb; Eli Lilly and Company; HealthPartners Institute Regions...

Active, not recruiting

Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma

Mesothelioma, Malignant

United States
Arkadiusz Z. Dudek, MD
Genentech, Inc.; Vanquish Oncology, Inc.; HealthPartners Regions Cancer Care... and other collaborators

Terminated

Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma

Uveal Melanoma

United States
Institut de Médecine et d'Epidémiologie Appliquée...
LAMBERT ASSOUMOU/ UNITE 1136 INSERM; Sebastien GALLIEN/Henri Mondor University... and other collaborators

Active, not recruiting

Pharmacokinetics of Calcineurin & mTOR Inhibitors in HIV-1 Infected Kidney Transplant Recipients After Switch to BIC/FTC/TAF (KINETIK)

HIV-infected Patient Kidney Transplant Recipient

France

Clinical Trials Sponsored by Ludek Stehlik

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations